Clinical trial
ImmuneSense™ COVID-19 Variant Study
NCT05054088 is registered in ClinicalTrials.gov with Adaptive Biotechnologies as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- ImmuneSense™ COVID-19 Variant Study
- Lead sponsor
- Adaptive Biotechnologies
- Phase
- Observational
- Overall status
- Completed
- Start date
- October 12, 2021
- Completion date
- July 28, 2022
- Enrollment
- 203 (actual)
- Sites
- 15
Conditions
As the registry lists them; a condition with its own page is linked.
covid19